Corneal Infection Models: Tools to Investigate the Role of Biofilms in Bacterial Keratitis
Lucy Urwin Katarzyna Okurowska Grace Crowther Sanhita Roy Prashant Garg Esther Karunakaran Sheila MacNeil Lynda J. Partridge Luke R. Green Peter N. Monk
Cells, 2020-11
Peter Monk
Monk Peter
ORCID: 0000-0003-4637-3059
Wild-type but not mutant SOD1 transgenic astrocytes promote the efficient generation of motor neuron progenitors from mouse embryonic stem cells 10.1186/1471-2202-14-126
C5a Receptor-Dependent Cell Activation by Physiological Concentrations of Desarginated C5a: Insights from a Novel Label-Free Cellular Assay 10.4049/jimmunol.1200834
International Union of Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors 10.1124/pr.111.005223
The Complement Factor C5a Contributes to Pathology in a Rat Model of Amyotrophic Lateral Sclerosis 10.4049/jimmunol.181.12.8727
C3a Chemotactic Peptide Receptor 10.1016/b978-008055232-3.60173-4
C5a Chemotactic Peptide Receptor 10.1016/b978-008055232-3.60174-6
Chemotactic Peptide Receptors 10.1016/b978-008055232-3.60172-2
The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein 10.1074/jbc.m206169200
C5a Mutants Are Potent Antagonists of the C5a Receptor (CD88) and of C5L2: POSITION 69 IS THE LOCUS THAT DETERMINES AGONISM OR ANTAGONISM 10.1074/jbc.m310078200
Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes 10.1371/journal.pone.0160387
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells 10.1126/science.aad1210
Different states of integrin LFA-1 aggregation are controlled through its association with tetraspanin CD9 10.1016/j.bbamcr.2015.05.018
Monocyte Subsets Have Distinct Patterns of Tetraspanin Expression and Different Capacities to Form Multinucleate Giant Cells 10.3389/fimmu.2018.01247
Inhibition of Tetraspanin Functions Impairs Human Papillomavirus and Cytomegalovirus Infections 10.3390/ijms19103007
A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function 10.1186/1471-2202-12-91
ALS: Life and death in a bad neighborhood 10.1038/nm0806-885
Adenosine triphosphate can maintain multipotent haemopoietic stem cells in the absence of interleukin 3 via a membrane permeabilization mechanism 10.1016/S0006-291X(88)80408-X
Analysis of receptor/ligand interactions using whole-molecule randomly-mutated ligand libraries 10.1016/S0022-1759(00)00282-9
Antibodies against human CD63 activate transfected rat basophilic leukemia (RBL-2H3) cells 10.1016/0161-5890(95)00113-1
Antibody cross-linking of human CD9 and the high-affinity immunoglobulin E receptor stimulates secretion from transfected rat basophilic leukaemia cells 10.1046/j.1365-2567.2000.00992.x
Astrocyte function and role in motor neuron disease: A future therapeutic target? 10.1002/glia.20848
C5L2 is a functional receptor for acylation-stimulating protein 10.1074/jbc.M406921200
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection 10.1128/JVI.78.3.1448-1455.2004
Characterisation of C5a receptor agonists from phage display libraries 10.1016/S0006-2952(03)00473-8
Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response 10.1016/j.molimm.2006.12.022
Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site 10.1074/jbc.M410797200
Complement C3a receptors in the pituitary gland: A novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation 10.1096/fj.02-1103fje
Complement C5a receptors in the pituitary gland: Expression and function 10.1677/JOE-08-0110
Complement component 5a (C5a) 10.1016/j.biocel.2009.04.005
Complement factors C3a and C5a have distinct hemodynamic effects in the rat 10.1016/j.intimp.2009.03.002
Contrasting effects of cerebrospinal fluid from motor neuron disease patients on the survival of primary motor neurons cultured with or without glia 10.3109/17482968.2011.560672
Cooperative role for tetraspanins in adhesin-mediated attachment of bacterial species to human epithelial cells 10.1128/IAI.01354-10
De novo peptide design with C3a receptor agonist and antagonist activities: Theoretical predictions and experimental validation 10.1021/jm201609k
Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells 10.1111/j.1365-2567.2008.02945.x
Embryonic stem cells and prospects for their use in regenerative medicine approaches to motor neurone disease 10.1111/j.1365-2990.2007.00883.x
Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms 10.1083/jcb.200805076
Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation 10.1182/blood-2004-09-3606
Function, structure and therapeutic potential of complement C5a receptors 10.1038/sj.bjp.0707332
Functional expression of chemokine receptor CXCR4 on human epithelial cells 10.1046/j.1365-2567.1999.00848.x
Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis 10.1096/fj.11-202382
Heterogeneity in the responses of human lung mast cells to stem cell factor 10.1111/cea.12045
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2 10.1128/JVI.74.8.3642-3649.2000
Interleukin-3-stimulated haemopoietic stem cell proliferation. Evidence for activation of protein kinase C and Na+/H+ exchange without inositol lipid hydrolysis. 10.1042/bj2560585
Interspecies contamination of the KM3 cell line: Implications for CD63 function in melanoma metastasis 10.1002/ijc.11144
Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines 10.1074/jbc.M609734200
Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor. 10.1021/bi011055w
Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis 10.1002/glia.20210
Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor 10.1016/S0006-2952(01)00608-6
Multiple signalling pathways in the C5a-induced expression of adhesion receptor Mac-1 10.1016/0167-4889(94)90257-7
Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1 10.1097/WNR.0b013e328331e8fa
Mutation of aspartate 82 of the human C5a receptor abolishes the secretory response to human C5a in transfected rat basophilic leukemia cells 10.1002/eji.1830241152
Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus 10.1074/jbc.270.28.16625
Receptor activation by human C5a des Arg(74) but not intact C5a is dependent on an interaction between Glu(199) of the receptor and Lys(68) of the ligand 10.1021/bi990139q
Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1 10.1128/JVI.02539-05
Regulation of zebrafish hatching by tetraspanin cd63 10.1371/journal.pone.0019683
S19 ribosomal protein dimer augments metal-induced apoptosis in a mouse fibroblastic cell line by ligation of the C5a receptor 10.1002/jcb.20318
STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: A comparative investigation in vitro 10.1007/s00441-003-0762-9
Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes 10.1023/A:1011036414353
Strategies for targeting tetraspanin proteins: Potential therapeutic applications in microbial infections 10.2165/11315650-000000000-00000
Structural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/oocyte binding and fusion 10.1016/j.bbrc.2003.09.196
Tc-99m-labeled C5a and C5a des Arg(74) for infection imaging 10.1016/S0969-8051(02)00440-7
Tetraspanins in viral infections: A fundamental role in viral biology? 10.1128/JVI.79.17.10839-10851.2005
The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization 10.1002/eji.1830270631
The human complement fragment receptor, C5L2, is a recycling decoy receptor 10.1016/j.molimm.2008.11.001
The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). 10.1074/jbc.C100714200
The role of protein kinase C activation and inositol phosphate production in the regulation of cell-surface expression of Mac-1 by complement fragment C5a 10.1016/0167-4889(91)90164-S
The role of tetraspanins in fusion 10.1042/BST0390524
The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding 10.1074/jbc.M609178200
The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9 10.1007/s00018-011-0639-0
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration 10.1096/fj.05-5814com
Complement peptide receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database 10.2218/gtopdb/F5/2019.4
Characterization of Ocular Clinical Isolates of Pseudomonas aeruginosa from Non-Contact Lens Related Keratitis Patients from South India 10.3390/microorganisms8020260
Hydrophobicity-Modulated Small Antibacterial Molecule Eradicates Biofilm with Potent Efficacy against Skin Infections 10.1021/acsinfecdis.9b00334
A role for tetraspanin proteins in regulating fusion induced by Burkholderia thailandensis 10.1007/s00430-020-00670-6
Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis 10.3791/61156
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signaling 10.1038/icb.2016.43
C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitment 10.1038/icb.2014.32
A role for the tetraspanin proteins in Salmonella infection of human macrophages 10.1016/j.jinf.2017.06.003
Distinct regions of the large extracellular domain of tetraspanin CD9 are involved in the control of human multinucleated giant cell formation 10.1371/journal.pone.0116289
Derivation of ligands for the complement C3a receptor from the C-terminus of C5a 10.1016/j.ejphar.2014.10.041
Changes and regulation of the c5a receptor on neutrophils during septic shock in humans 10.4049/jimmunol.1200534
Tspan2: A tetraspanin protein involved in oligodendrogenesis and cancer metastasis 10.1042/BST20160022
Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans 10.4049/jimmunol.174.2.1104
Tetraspanins: gateways for infection. 10.2174/187152612798994957
Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81 10.1128/jvi.73.8.6235-6244.1999
The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors 10.1111/bph.13348
The Concise Guide to PHARMACOLOGY 2013/14: Ligand-Gated Ion Channels 10.1111/bph.12446
The influence of Lys68 in decapeptide agonists of C5a on C5a receptor binding, activation and selectivity 10.1111/j.1399-3011.1999.tb01612.x
Auto-regulation of Th1 responses through carboxypeptidase M-generated C5a-desArg 10.1016/j.molimm.2017.06.073
Post-translational modification of complement anaphylatoxins during chronic neutrophilic inflammation 10.1016/j.molimm.2017.06.141
Tetraspanins in zebrafish development 10.1016/j.mod.2017.04.142
Structure-function relationships of leucocyte chemoattractant receptors. 10.1042/bst0251027
Defective protein phosphorylation and Ca2+ mobilization in a low secreting variant of the rat basophilic leukemia cell line. 10.1016/s0021-9258(17)32167-1
Characterization of a complement-fragment-C5a-stimulated calcium-influx mechanism in U937 monocytic cells. 10.1042/bj2950679
The regulation of actin polymerization in differentiating U937 cells correlates with increased membrane levels of the pertussis-toxin-sensitive G-protein Gi2. 10.1042/bj2750809
Evidence for the involvement of multiple signalling pathways in C5a-induced actin polymerization and nucleation in human monocyte-like cells. 10.1677/jme.0.0060241
Platelet-activating factor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate stimulates the production of reactive oxygen intermediates in macrophages. 10.1042/bj2490839
Interleukin 3 stimulates proliferation via protein kinase C activation without increasing inositol lipid turnover. 10.1073/pnas.85.10.3284
Auto-regulation of Th1 responses through carboxypeptidase M-generated C5a-desArg 10.1016/j.imbio.2016.06.120
De novo protein design of agonists and antagonists of C5a receptors 10.1016/j.imbio.2012.08.097
Modelling of the C5a receptor by iterative mutation 10.1016/j.molimm.2010.05.061
Novel haemodynamic effects of recombinant C5a and C5a des Arg in rats and mice 10.1016/j.molimm.2008.08.165
Constitutive recycling of the C5a-receptor like protein, C5L2 10.1016/j.molimm.2007.06.058
Evidence that the C5a-receptor like protein (C5L2) acts a decoy receptor for anaphylatoxins, C5a and C5adesR(74) 10.1016/j.molimm.2006.07.213
Abstract LB-036: Tetraspanin 5 expressing macrophages promote mammary tumor growth 10.1158/1538-7445.am2019-lb-036
Different ligand-binding mechanisms used by the two C5a receptors, C5L2 and C5aR 10.1016/j.molimm.2006.07.212
Role of novel orphan receptor C5L2 during sepsis in humans 10.1097/00024382-200403001-00102
Selection of novel ligands from a whole-molecule randomly mutated C5a library. 10.1093/protein/14.3.189
Pharmacological characterization of antagonists of the C5a receptor 10.1038/sj.bjp.0702938
Auto-regulation of Th1 responses requires intracellular carboxypeptidase M-mediated complement regulation 10.1016/j.molimm.2018.06.246
C5aR-dependent cell activation by physiological concentrations of C5a-desArg: Insights from a novel label-free cellular assay 10.1016/j.imbio.2012.08.053
Structure-function relationships of leucocyte chemoattractant receptors 10.1042/bst025428sc
Chemokine and chemoattractant receptor expression on human endothelial cells 10.1016/s0165-2478(97)85401-6
Studies on the interaction between human C5a and its receptor 10.1016/s0165-2478(97)85433-8
The functional capacity of chemoattractant receptors expressed on RBL cells correlates with their rates of internalization 10.1016/s0165-2478(97)85400-4
P3-267: Loss of C5L2, an anti-inflammatory complement receptor in AD frontal cortex 10.1016/j.jalz.2006.05.1536
Verlust des neuen Decoy Rezeptors C5L2 während der experimentellen und klinischen Sepsis 10.1007/3-540-26560-0_73
Abstract LB-036: Tetraspanin 5 expressing macrophages promote mammary tumor growth 10.1158/1538-7445.sabcs18-lb-036
The influence of biofilm formation on carbapenem resistance in clinical Klebsiella pneumoniae infections: phenotype vs genome-wide analysis 10.1101/2020.07.03.186130
ACE2-independent interaction of SARS-CoV-2 spike protein to human epithelial cells can be inhibited by unfractionated heparin 10.1101/2020.05.21.107870
Tetraspanins are involved in Burkholderia pseudomallei-induced cell-to-cell fusion of phagocytic and non-phagocytic cells 10.1038/s41598-020-74737-y
Corneal Infection Models: Tools to Investigate the Role of Biofilms in Bacterial Keratitis 10.3390/cells9112450
Complement peptide receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database 10.2218/gtopdb/F5/2020.5
Correction to: A role for tetraspanin proteins in regulating fusion induced by Burkholderia thailandensis 10.1007/s00430-020-00682-2
The influence of biofilms on carbapenem susceptibility and patient outcome in device associated K. pneumoniae infections : insights Into phenotype vs genome-wide analysis and correlation 10.3389/fmicb.2020.591679
CD9 tetraspanins convey robustness to CXCR4b signalling during collective cell migration 10.1101/2021.05.19.444012
ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin 10.3390/cells10061419
Esther Karunakaran
Karunakaran Esther
ORCID: 0000-0003-1913-4319
Characterization of Ocular Clinical Isolates of Pseudomonas aeruginosa from Non-Contact Lens Related Keratitis Patients from South India 10.3390/microorganisms8020260
Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis 10.3791/61156
Metabolic Insights Into Infochemicals Induced Colony Formation and Flocculation in Scenedesmus subspicatus Unraveled by Quantitative Proteomics 10.3389/fmicb.2020.00792
Publisher Correction: Deciphering the unique cellulose degradation mechanism of the ruminal bacterium Fibrobacter succinogenes S85 10.1038/s41598-019-55971-5
Designing synthetic bacterial consortia for landfill leachate treatment based on community matrices and regression tree analysis 10.1101/543694
The alternative sigma factor SigF is a key player in the control of secretion mechanisms in Synechocystis sp. PCC 6803 10.1111/1462-2920.14465
Corneal Infection Models: Tools to Investigate the Role of Biofilms in Bacterial Keratitis 10.3390/cells9112450
Katarzyna Emery
Emery Katarzyna
ORCID: 0000-0002-6460-1468
Establishing a porcine ex vivo cornea model for studying drug treatments against bacterial keratitis 10.3791/61156
Adapting the algal microbiome for growth on domestic landfill leachate 10.1016/j.biortech.2020.124246
Effects of cryopreservation on viability and functional stability of an industrially relevant alga 10.1038/s41598-019-38588-6
Effect of ammonium and high light intensity on the accumulation of lipids in Nannochloropsis oceanica (CCAP 849/10) and Phaeodactylum tricornutum (CCAP 1055/1) 10.1186/s13068-018-1061-8
Pathways to economic viability : a pilot scale and techno-economic assessment for algal bioremediation of challenging waste streams 10.1039/D0EW00700E
Corneal infection models : tools to investigate the role of biofilms in bacterial keratitis 10.3390/cells9112450
Enabling large-scale production of algal oil in continuous output mode 10.1016/j.isci.2021.102743
Lucy Urwin
Urwin Lucy
ORCID: 0000-0002-7667-8630
Corneal Infection Models: Tools to Investigate the Role of Biofilms in Bacterial Keratitis 10.3390/cells9112450
ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin 10.3390/cells10061419
Prashant Garg
Garg Prashant
ORCID: 0000-0003-4989-2815
Outcome of transplanted donor corneas with more than 6 h of death-to-preservation time 10.4103/0301-4738.194338
Commentary: Pseudopestalotiopsis theae keratitis 10.4103/ijo.IJO_1490_18
Pythium insidiosum keratitis: Clinical profile and role of DNA sequencing and zoospore formation in diagnosis 10.1097/ICO.0000000000000349
Outcomes of Corneal Transplantation Using Donor Corneas Retrieved from Snakebite Victims 10.1097/ICO.0000000000001953
Microsporidial stromal keratitis successfully treated with medical therapy: A case report 10.1097/ICO.0b013e31821d876d
Oestrus ovis ophthalmomyiasis with keratitis 10.4103/0255-0857.71846
Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: Experience of over a decade 10.4103/0301-4738.53051
Clinical experience with N-butyl cyanoacrylate tissue adhesive in fungal keratitis 10.1097/00003226-200307000-00003
Fungal Infection of Sutureless Self-sealing Incision for Cataract Surgery 10.1016/S0161-6420(03)00861-3
Endophthalmitis after cataract surgery: Epidemiology, risk factors, and evidence on protection 10.1097/ICU.0000000000000326
Differential expression of antimicrobial peptides in corneal infection and regulation of antimicrobial peptides and reactive oxygen species by type III secretion system of Pseudomonas aeruginosa 10.1093/femspd/fty001
An outbreak of acute post-cataract surgery pseudomonas sp. endophthalmitis caused by contaminated hydrophilic intraocular lens solution 10.1016/j.ophtha.2011.09.031
Bilateral spontaneous rupture of the anterior capsule 10.1016/j.jcrs.2008.04.032
Lamellar Keratoplasty 10.1016/j.ophtha.2008.08.047
Optimizing diagnosis and management of Nocardia keratitis, scleritis, and endophthalmitis: 11-year microbial and clinical overview 10.1016/j.ophtha.2010.10.037
Corneal edema with dislocated anterior polar cataract 10.1016/S0002-9394(01)01324-1
High-resolution genome profiling differentiated Staphylococcus epidermidis isolated from patients with ocular infections and normal individuals 10.1167/iovs.06-1365
Repeat endothelial keratoplasty 10.1016/j.ophtha.2011.03.007
Infectious keratitis in climatic droplet keratopathy 10.1097/00003226-200007000-00009
Outcomes of Descemet's stripping endothelial keratoplasty in eyes with failed therapeutic penetrating keratoplasty 10.1111/aos.12033
Evaluation of medical college departments of ophthalmology in India 10.4103/0301-4738.44503
Role of confocal microscopy in the diagnosis of fungal and acanthamoeba keratitis 10.1016/j.ophtha.2010.05.018
Evaluation of three PCR assays for the detection of fungi in patients with mycotic keratitis 10.1136/bjophthalmol-2011-300207
Bilateral infectious keratitis after laser in situ keratomileusis: A case report and review of the literature 10.1016/S0161-6420(00)00435-8
Keratocyte loss in corneal infection through apoptosis: A histologic study of 59 cases 10.1186/1471-2415-4-16
Ciprofloxacin-resistant Pseudomonas keratitis 10.1016/S0161-6420(99)00717-4
Relation between uncorrected astigmatism and visual acuity in pseudophakia 10.1097/OPX.0b013e318288afb5
Clinical profile of graft detachment and outcomes of rebubbling after Descemet stripping endothelial keratoplasty 10.1136/bjophthalmol-2011-300155
Bilateral granular dystrophy: A clinicopathogenetic correlation after alcohol assisted debridement with phototherapeutic keratectomy 10.1016/j.mjafi.2012.08.023
Pupillary block glaucoma after tissue adhesive application and anterior chamber reformation with air 10.1097/00003226-200003000-00026
Ex vivo rabbit and human corneas as models for bacterial and fungal keratitis 10.1007/s00417-016-3546-0
Role of confocal microscopy in deep fungal keratitis 10.1097/ICO.0b013e318181cff7
Re: Said et al.: Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting (Ophthalmology 2014;121:1377-82) 10.1016/j.ophtha.2014.06.043
Uveitis-glaucoma-hyphaema syndrome with in-the-bag placement of intraocular lens 10.1136/bcr-2015-213745
Clinico-microbiological review of non-contact-lens-associated acanthamoeba keratitis 10.3109/08820538.2013.849270
Aspergillus fumigatus keratitis with wreath pattern infiltrates 10.1097/00003226-200107000-00019
PCR for the diagnosis and species identification of microsporidia in patients with keratitis 10.1111/j.1469-0691.2010.03152.x
Outcome of pterygium surgery: Analysis over 14 years 10.1038/sj.eye.6701728
The value of corneal transplantation in reducing blindness 10.1038/sj.eye.6701968
Alcohol epitheliectomy with mechanical debridement in a case of granular corneal dystrophy with r555w homozygous mutation of TGF B1 gene 10.4103/0301-4738.64126
Pathogenesis of pterygium: Role of Eph receptors and ligand ephrins,La pathogenèse du ptérygion : le rǒle des récepteurs Eph et des éphrines du ligand 10.3129/i09-038
Lasik infectious keratitis 10.1016/j.ophtha.2010.09.027
Leap forward in the treatment of Pythium insidiosum keratitis 10.1136/bjophthalmol-2017-311360
Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India 10.1038/eye.2009.29
Dictyostelium polycephalum infection of human cornea 10.3201/eid1610.100717
Clinical outcomes and risk factors for graft failure after deep anterior lamellar keratoplasty and penetrating keratoplasty for macular corneal dystrophy 10.1097/ICO.0000000000000327
Pseudomonas keratitis with satellite lesions: An unusual presentation 10.1136/bjo.2009.172171
Propionibacterium acnes as a cause of visually significant corneal ulcers 10.1097/00003226-200105000-00023
Prospective, Randomized Clinical Trial of Povidone-Iodine 1.25% Solution Versus Topical Antibiotics for Treatment of Bacterial Keratitis 10.1016/j.ajo.2016.10.004
Donor corneal button-related endophthalmitis after penetrating keratoplasty 10.1111/j.1442-9071.2010.02204.x
Risk factors and clinical outcomes of bacterial and fungal scleritis at a tertiary eye care hospital 10.4103/0974-9233.150634
Microbial analyses of contact lens-associated microbial keratitis 10.1097/OPX.0000000000000082
Trends in contact lens-associated microbial keratitis in Southern India 10.1016/S0161-6420(02)01283-6
Is microsporidial keratitis an emerging cause of stromal keratitis? - A case series study 10.1186/1471-2415-5-19
Correction: Alterations in the gut bacterial microbiome in fungal Keratitis patients(PLoS ONE (2018) 13:6 (e0199640) DOI: 10.1371/journal.pone.0199640) 10.1371/journal.pone.0211757
Keratomycosis: Clinical and microbiologic experience with dematiaceous fungi 10.1016/S0161-6420(99)00079-2
Novel drug delivery methods for the treatment of keratitis: moving away from surgical intervention 10.1080/17425247.2019.1690451
The epidemiological features and laboratory results of fungal keratitis: A 10-year review at a referral eye care center in South India 10.1097/00003226-200208000-00004
Differential expression of antimicrobial peptides in streptococcus pneumoniae keratitis and STAT3-dependent expression of LL-37 by streptococcus pneumoniae in human corneal epithelial cells 10.3390/pathogens8010031
Outcomes of Repeat Keratoplasty for Failed Therapeutic Keratoplasty 10.1016/j.ajo.2015.11.004
Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial 10.1136/bjophthalmol-2014-306485
Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11 10.1136/jmg.2006.044644
In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis 10.3109/02713680903502258
Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis 10.1016/j.ijpharm.2019.118808
Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis 10.4103/0301-4738.40369
Binocular vision of bilaterally pseudophakic eyes with induced astigmatism 10.1097/OPX.0000000000000359
Diagnosis of microbial keratitis 10.1136/bjo.2010.182550
The International Council of Ophthalmology 360-degree assessment tool: development and validation 10.1016/j.jcjo.2017.09.002
Natamycin in the treatment of keratomycosis: Correlation of treatment outcome and in vitro susceptibility of fungal isolates 10.4103/0301-4738.86328
Mycobacterium chelonei masquerading as Corynebacterium in a case of infectious keratitis: A diagnostic dilemma 10.1097/00003226-199803000-00021
Antibiotic functionalised polymers reduce bacterial biofilm and bioburden in a simulated infection of the cornea 10.1039/c8bm00201k
Update on fungal keratitis 10.1097/ICU.0000000000000272
Microbial scleritis - Experience from a developing country 10.1038/sj.eye.6703099
Use of different stains for microscopic evaluation of corneal scrapings for diagnosis of microsporidial keratitis 10.1128/JCM.44.2.583-585.2006
Deep anterior lamellar keratoplasty in children 10.1016/j.ajo.2012.09.029
Traumatic fracture of posterior chamber intraocular lens 10.1016/j.jcrs.2007.07.054
Penetrating keratoplasty in children 10.1097/00003226-200003000-00004
Image quality analysis of pseudophakic eyes with uncorrected astigmatism 10.1097/OPX.0000000000000192
Corneal ulceration in the elderly in Hyderabad, south India 10.1136/bjo.84.1.54
Altered tear inflammatory profile in Indian keratoconus patients 10.4103/ijo.IJO_838_17
Fungal, Mycobacterial, and Nocardia infections and the eye: An update 10.1038/eye.2011.332
Diagnosis of herpes simplex virus-1 keratitis using Giemsa stain, immunofluorescence assay, and polymerase chain reaction assay on corneal scrapings 10.1136/bjo.88.1.142
3-Day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: Multicentre, randomised and controlled trial in adults and children 10.1136/bjo.2006.103556
Treatment outcome of Moraxella keratitis: Our experience with 18 cases a retrospective review 10.1097/00003226-199903000-00006
Alterations in the gut bacterial microbiome in fungal Keratitis patients 10.1371/journal.pone.0199640
Procurement, storage and utilization trends of eye banks in India 10.4103/ijo.IJO_1551_18
Histopathological evaluation of ocular microsporidiosis by different stains 10.1186/1472-6890-6-6
Outcomes of air descemetopexy for Descemet membrane detachment after cataract surgery 10.1016/j.jcrs.2012.01.030
Speciation and susceptibility of Nocardia isolated from ocular infections 10.1111/j.1469-0691.2009.03079.x
Collagen cross-linking for microbial keratitis 10.4103/meajo.MEAJO_305_16
Ocular nocardia infections with special emphasis on the cornea 10.1016/S0039-6257(00)00207-1
Coexistent congenital hereditary endothelial dystrophy and congenital glaucoma 10.1097/ICO.0b013e31804e4579
Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis 10.1136/bjo.84.10.1103
In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin: Emerging resistance 10.1016/S0161-6420(99)90008-8
Precut cornea for Descemet’s stripping endothelial keratoplasty: experience at a single eye bank 10.1007/s10792-016-0297-1
Long-term change in corneal astigmatism after sutureless cataract surgery 10.1016/j.ajo.2011.08.014
The Asia Cornea Society Infectious Keratitis Study: A Prospective Multicenter Study of Infectious Keratitis in Asia 10.1016/j.ajo.2018.07.040
Outcome of corneal transplant rejection: A 10-year study 10.1111/j.1442-9071.2005.01107.x
Aspergillus flavus keratitis after laser in situ keratomileusis 10.1016/S0002-9394(00)00406-2
Endothelial keratoplasty without stripping the Descemet's membrane 10.1136/bjo.2011.204008
Investigative modalities in infectious keratitis 10.4103/0301-4738.45512
Commentary: Pythium insidiosum keratitis 10.4103/ijo.IJO_1491_18
Spectrum and clinicomicrobiological profile of Nocardia keratitis caused by rare species of Nocardia identified by 16S rRNA gene sequencing 10.1038/eye.2009.299
Lamellar keratoplasty for the treatment of fungal keratitis 10.1097/00003226-200210000-00025
Corneal delivery of besifloxacin using rapidly dissolving polymeric microneedles 10.1007/s13346-017-0470-8
Clinical and microbiological profile of Bacillus keratitis 10.1097/00003226-200005000-00009
Microsporidial stromal keratitis: Clinical features, unique diagnostic criteria, and treatment outcomes in a large case series 10.1097/ICO.0000000000000939
Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones 10.1089/jop.2018.0059
Is microsporidial keratitis a seasonal infection in India? 10.1111/j.1469-0691.2010.03084.x
Outcomes of keratoplasty in lattice corneal dystrophy in a large cohort of Indian eyes 10.4103/ijo.IJO_1150_17
Roles of adherence and matrix metalloproteinases in growth patterns of fungal pathogens in cornea 10.1080/02713680600669397
Microbial keratitis following vegetative matter injury 10.1007/s10792-012-9643-0
Epithelial infectious crystalline keratopathy 10.1016/S0002-9394(00)00712-1
Training the eye care team: Principles and practice 10.4103/0974-9233.129757
Fungal keratitis after laser in situ keratomileusis 10.1016/S0886-3350(99)00459-9
Non-contact lens related Acanthamoeba keratitis 10.4103/ijo.IJO_826_17
Phenotypic and genotypic characterization of coagulase negative staphylococci (CoNS) other than staphylococcus epidermidis isolated from ocular infections 10.1167/iovs.11-7777
Corneal transplantation in disease affecting only one eye: Does it make a difference to habitual binocular viewing? 10.1371/journal.pone.0150118
Surgical management of fungal keratitis 10.1080/17469899.2018.1555032
Microsporidia infection of the cornea-a unique and challenging disease 10.1097/ICO.0b013e3182a2c91f
Analysis of resident-performed manual small incision cataract surgery (MSICS): An efficacious approach to mature cataracts 10.1007/s10792-012-9605-6
Re: Ang et al: Descemet's stripping automated endothelial keratoplasty with anterior chamber intraocular lenses: Complications and 3-year outcomes 10.1136/bjophthalmol-2014-305753
Efficacy of Topical Miltefosine in Patients with Acanthamoeba Keratitis: A Pilot Study 10.1016/j.ophtha.2018.12.028
Decreased susceptibility to quinolones in methicillin-resistant Staphylococcus aureus isolated from ocular infections at a tertiary eye care centre 10.1136/bjo.2010.179747
Treatment and outcome of Nocardia keratitis 10.1097/00003226-200107000-00003
Corneal collagen cross-linkage,inkeratoconus 10.1136/bjophthalmol-2012-302322
Microsporidial keratitis in India: 16s rRNA gene-based PCR assay for diagnosis and species identification of microsporidia in clinical samples 10.1167/iovs.06-0376
Pythium Insidiosum Keratitis: Histopathology and Rapid Novel Diagnostic Staining Technique 10.1097/ICO.0000000000001463
Use of 18S rRNA gene-based PCR assay for diagnosis of Acanthamoeba keratitis in non-contact lens wearers in India 10.1128/JCM.41.7.3206-3211.2003
KOH mount as an aid in the management of infectious keratitis at secondary eye care centre 10.1136/bjophthalmol-2017-310241
Nocardia infection following phacoemulsification 10.4103/0301-4738.29498
Erratum: Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11 (Journal of Medical Genetics (2007) 44, (64-68)) 10.1136/jmg.2006.044644corr1
Pigmented plaque presentation of dematiaceous fungal keratitis: A clinicopathologic correlation 10.1097/01.ico.0000126318.90271.3c
Alterations in gut bacterial and fungal microbiomes are associated with bacterial Keratitis, an inflammatory disease of the human eye 10.1007/s12038-018-9798-6
Atypical herpes simplex keratitis (HSK) presenting as a perforated corneal ulcer with a large infiltrate in a contact lens wearer: Multinucleated giant cells in the Giemsa smear offered a clue to the diagnosis 10.1186/1471-2415-1-1
Comparison of clinical and microbiological profiles in smear-positive and smear-negative cases of suspected microbial keratitis 10.4103/0301-4738.29490
Posterior capsule dehiscence during phacoemulsification and manual extracapsular cataract extraction: Comparison of outcomes 10.1016/S0886-3350(02)01696-6
Endothelial keratoplasty in the management of irido-corneal endothelial syndrome 10.1038/eye.2012.298
Clinical and Antibacterial Efficacy and Safety of Besifloxacin Ophthalmic Suspension Compared With Moxifloxacin Ophthalmic Solution 10.1097/APO.0000000000000055
Broken suture - Predisposing factor for Nocardia keratitis 10.1038/eye.2000.31
Evaluation of agent and host factors in progression of mycotic keratitis: A histologic and microbiologic study of 167 corneal buttons 10.1016/S0161-6420(02)01088-6
Confocal Microscopy for Nocardia Keratitis 10.1016/j.ophtha.2006.03.054
Sutureless wound infection by unusual acid-fast organisms 10.1097/ICO.0b013e318166efdf
Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea? 10.1586/eop.12.72
Primary graft failure after big bubble deep anterior lamellar keratoplasty in macular corneal dystrophy 10.4103/ijo.IJO_220_18
Effect of transfer of donor corneal tissue from McCarey-Kaufman medium to Optisol on corneal endothelium 10.4103/ijo.IJO_1135_17
Microsporidial keratoconjunctivitis in an immunocompetent patient with a past history of laser in situ keratomilieusis surgery 10.4103/0255-0857.90189
Microbial keratitis after LASIK 10.3928/1081597X-20100224-07
Thirty years of eye bank experience at a single centre in India 10.1007/s10792-019-01164-y
Evaluation of corneal scraping smear examination methods in the diagnosis of bacterial and fungal keratitis: A survey of eight years of laboratory experience 10.1097/00003226-200210000-00002
Characterization of Ocular Clinical Isolates of Pseudomonas aeruginosa from Non-Contact Lens Related Keratitis Patients from South India 10.3390/microorganisms8020260
The epidemiological features and laboratory results of fungal keratitis - A 10-year review at a referral eye care center in south India 10.1097/01.ICO.0000022924.90020.30
The value of corneal transplantation in reducing blindness 10.1038/SI.EYE.6701968
Bilateral peripheral infiltrative keratitis after LASIK 10.3928/1081-597X-20050701-18
Acanthamoeba keratitis after LASIK 10.3928/1081-597X-20060601-17
A cluster of nocardial keratitis after LASIK 10.3928/1081-597X-20070301-17
Authors reply 10.1093/SW/25.4.335-A
Investigative modalities in infectious keratitis 10.4103/0301-4738.40359
Clinical, Microbiological Profile and Treatment Outcome of Ocular Infections Caused by Achromobacter xylosoxidans 10.1097/ICO.0B013E3181A1658F
Endothelial Keratoplasty: A Review of Indications at a Tertiary Eye Care Centre in South India 10.1097/APO.0B013E3182A75304
Microbial Keratitis Due to Aeromonas Species at a Tertiary Eye Care Center in Southern India 10.1097/APO.0000000000000018
Alterations in the Ocular Surface Fungal Microbiome in Fungal Keratitis Patients 10.3390/MICROORGANISMS7090309
Infectious corneal ulceration: a proposal for neglected tropical disease status 10.2471/BLT.19.232660
Management of severe Acanthamoeba keratitis and complicated cataract following laser in situ keratomileusis 10.4103/IJO.IJO_492_19
Outcome of therapeutic deep anterior lamellar keratoplasty in advanced Acanthamoeba keratitis 10.4103/IJO.IJO_307_19
Cyclam-based antibacterial molecules eradicate Gram-negative superbugs with potent efficacy against human corneal infection 10.1039/C9CC06967D
Corneal Infection Models: Tools to Investigate the Role of Biofilms in Bacterial Keratitis 10.3390/cells9112450
A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of Acanthamoeba keratitis 10.1038/s41433-020-1109-4
Response to ‘Comment on: ‘A randomized masked pilot clinical trial to compare the efficacy of topical 1% Voriconazole ophthalmic solution as monotherapy to combination therapy with topical 0.02% Polyhexamethylene biguanide and 0.02% Chlorhexidine in the treatment of Acanthamoeba keratitis’’ 10.1038/s41433-021-01401-8